Literature DB >> 726518

Identification of some urinary metabolites of propantheline bromide in man.

C W Vose, M Prout, N J Haskins, C Ford, R F Palmer, M J Tidd.   

Abstract

The peak plasma concn. of total radioactivity occurred 6 h after a single oral dose of [carboxyl-14C; methyl-2H3] propantheline bromide was administered to a healthy man. At this time 10% of the dose was present in the total plasma volume. 2. A total of 71% dose of radioactivity was excreted in urine in 96 h after dosage, 59% dose being excreted in the first 24 h. About 5.3% of the orally administered propantheline bromide was excreted unchanged. 3. T.l.c. analysis and g.l.c.-mass spectrometry showed xanthanoic acid, hydroxyxanthanoic acid(s), and propantheline as urinary metabolites of the drug. 4. A glucuronide of xanthanoic acid, a hydroxylated propantheline and the (2-hydroxyethyl)diisopropylammonium ion were tentatively identified as urinary metabolites. Hydrolysis of propantheline and conjugation of the resulting xanthanoic acid appear to be the major routes of metabolism of this compound. 5. A mean elimination half-life of 9.2 h was obtained for the total radioactivity by pharmacokinetic analysis of plasma and urine levels of 14C.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 726518     DOI: 10.3109/00498257809069587

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

1.  Propantheline bromide plasma level, urinary excretion and pharmacological data in a comparison of the bioavailability of three oral formulations of Pro-Banthine.

Authors:  G V Rigby; C W Vose; N J Haskins; E F Allan; I R Harrison; J R Shelton; R D Brownsill; R M Perkins; G C Ford; A J Hawkins
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

Review 2.  Clinical pharmacokinetics of drugs used to treat urge incontinence.

Authors:  David R P Guay
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Plasma levels and urinary excretion of orally administered propantheline bromide in man.

Authors:  C W Vose; P M Stevens; N J Haskins; K A Waddell; A J Hawkins; D A Rose; G L Evans; R F Palmer; V Diaz; J Garza; O Martin; H Rudel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.